anti-LMO2 (LMO2) 抗体产品概述

Mouse (Murine) LIM Domain Only 2 (Rhombotin-Like 1) (LMO2) interaction partners

1. Trichostatin A (TSA (显示 PRDX2 抗体), a HDAC (显示 HDAC3 抗体) inhibitor) addition significantly attenuates MTX (显示 MTX1 抗体) unsensitivity caused by dysfunction of LMO2/ZEB1 (显示 ZEB1 抗体) signaling. In conclusion, these findings have identified a molecular mechanism underlying LMO2/ZEB1 (显示 ZEB1 抗体)-mediated leukaemogenesis, paving a way for treating T-ALL with a new strategy of epigenetic inhibitors.

2. Genome-wide analysis indicated that LMO2 is required at the hemangioblast stage to position the TAL1 (显示 TAL1 抗体)/LMO2/LDB1 (显示 LDB1 抗体) complex to regulatory elements that are important for the establishment of the hematopoietic developmental program.

3. DNM2 (显示 DNM2 抗体) mutations cooperate with Lmo2 T-cell oncogenes by enhancing IL-7 (显示 IL7 抗体) signalling.

4. Hhex (显示 HHEX 抗体) regulates Kit to promote radioresistance of self-renewing thymocytes in Lmo2-transgenic mice.

5. HHEX (显示 HHEX 抗体) is a direct transcriptional target of LMO2 consistent with its concordant gene expression.

6. GATA2 (显示 GATA2 抗体) and Lmo2 cooperatively regulate VEGF (显示 VEGFA 抗体)-induced angiogenesis and lymphangiogenesis via NRP2 (显示 NRP2 抗体).

7. a regulatory hierarchy of HOX control of LMO2 in normal development

8. Lyl1 is critical for all oncogenic functions of Lmo2, including upregulation of a stem cell-like gene signature, aberrant self-renewal of thymocytes, and subsequent generation of T-cell leukemia.

9. A model in which the distal control region functions through a chromatin looping mechanism to contact and enhance Lmo2 transcription specifically in erythroid cells.

10. Studied the solution structure of Lmo2(LIM2 (显示 LHX2 抗体)) /Ldb1 (显示 LDB1 抗体)(LID) complex. Results show modular binding of tandem LIM (显示 PDLIM5 抗体) domains in Lmo2 to tandem linear motifs in Ldb1 (显示 LDB1 抗体) is accompanied by several disorder-to-order transitions/ conformational changes in both proteins.

Human LIM Domain Only 2 (Rhombotin-Like 1) (LMO2) interaction partners

1. the data in this study revealed a novel crosstalk between LMO2 and the Wnt (显示 WNT2 抗体) signaling pathway during tumorigenesis and suggested that LMO2 might be a tumor suppressor in certain solid tumors.

2. LMO2 has a predominantly cytoplasmic location in breast cancer cells. LMO2 interaction with cofilin1 regulates actin cytoskeleton dynamics, promoting tumor cell invasion and metastasis.

3. These data indicate that Lhx2 (显示 LHX2 抗体) is capable of blocking proliferation of T-ALL-derived cells by both LMO2-dependent and -independent means. We propose Lhx2 (显示 LHX2 抗体) as a new molecular tool for anti-T-ALL drug development.

4. stromal LMO2 may be responsible for zonal characteristic of Prostate cancer

5. The transcriptional factor LMO2 regulates endothelial proliferation and angiogenesis in vitro.

6. This article demonstrates a novel and unexpected function of the LMO2 oncogenic transcription factor in controlling DNA replication that we unravelled via an unbiased proteome-wide screen for LMO2-interacting partners.

7. Findings suggest that LMO2 loss may be a good predictor for the presence of MYC (显示 MYC 抗体) translocation in large B-cell lymphoma.

8. FOXP3 (显示 FOXP3 抗体) binds LMO2 in vitro, resulting in decreased interaction between LMO2 and TAL1 (显示 TAL1 抗体), providing a molecular mechanism for FOXP3 (显示 FOXP3 抗体)-mediated transcriptional modulation in T-ALL.

9. recurrent activating intronic mutations of LMO2, a prominent oncogene (显示 RAB1A 抗体) in T-cell acute lymphoblastic leukemia (T-ALL). Heterozygous mutations were identified in PF-382 and DU.528 T-ALL cell lines in addition to 3.7% of pediatric (6 of 160) and 5.5% of adult (9 of 163) T-ALL patient samples.

10. Data indicate a novel functional mechanism of LMO2 in facilitating the delivery of actin monomers to the branched microfilament and increasing lamellipodia/filopodia formation in basal-type breast cancer cells.

Zebrafish LIM Domain Only 2 (Rhombotin-Like 1) (LMO2) interaction partners

1. The transcriptional factor LMO2 regulates endothelial proliferation and angiogenesis in vitro. Furthermore, LMO2 is required for angiogenesis and tissue healing in vivo. Thus, LMO2 is a critical determinant of vascular and tissue regeneration.

2. a loss-of-function mutation in lmo2, a gene specifically required for hematopoiesis and vascular development, results in failure of optic fissure closure

3. in the absence of inducers of erythroid or myeloid haematopoiesis, Scl/Tal1 (显示 TAL1 抗体)-Lmo2-induced haemangioblasts differentiate into endothelial cells

4. Transcriptional regulation of lmo2 promoter during hematopoietic and vascular development in zebrafish is elucidated.

5. Scl (显示 TAL1 抗体)/Lmo2 complex does not appear to autoregulate, as neither gene's expression is affected by depletion of the other